Alembic Pharmaceuticals LimitedNSE: APLLTD

Press Release Jun 28 2024

Jun 28, 2024 at 2:55 PM UTC · Issued by Alembic Pharmaceuticals Limited

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 28, 2024, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Doxycycline Capsules, 40 mg".

View Attachment